About NEURODIAGNOSTICS, INC.
Synaps Dx is a diagnostic company specializing in Alzheimer’s disease detection through its DISCERN™ test, a gold standard validated skin biopsy test. The company aims to improve healthcare by providing accurate diagnostic tools to help patients and clinicians make informed treatment decisions.
Development and provision of DISCERN™, a gold standard validated skin biopsy test for Alzheimer’s diseaseDistinguishing Alzheimer’s disease from other forms of dementiaSupporting healthcare professionals with scientific data for accurate diagnosisOffering the test for use in clinical trials and research
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NEURODIAGNOSTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.